{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T05:39:25Z","timestamp":1737005965134,"version":"3.33.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.leukres.2020.106427","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T22:38:54Z","timestamp":1736980734000},"page":"106427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peyronie\u2019s disease in patients with Hodgkin lymphoma"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-7469","authenticated-orcid":false,"given":"Francesco","family":"Autore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Massini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarosa","family":"Cuccaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-7469","authenticated-orcid":false,"given":"Francesco","family":"D\u2019Al\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7214-1561","authenticated-orcid":false,"given":"Luciana","family":"Teofili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2020.106427_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.leukres.2020.106427_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ijir.2008.30","article-title":"Review: peyronie\u2019s disease: a critical appraisal of current diagnosis and treatment","volume":"20","author":"Smith","year":"2008","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.leukres.2020.106427_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.leukres.2020.106427_bib0020","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkin\u2019s lymphoma: increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2020.106427_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pupt.2005.01.007","article-title":"Bleomycin lung toxicity: who are the patients with increased risk?","volume":"18","author":"Azambuja","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.leukres.2020.106427_bib0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","article-title":"MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma","volume":"102","author":"Klimo","year":"1985","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.leukres.2020.106427_bib0035","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/annonc\/9.suppl_5.S67","article-title":"BEACOPP: a new regimen for advanced Hodgkin\u2019s disease. German Hodgkin\u2019s Lymphoma Study Group","volume":"9","author":"Diehl","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2020.106427_bib0040","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1023\/A:1008329127887","article-title":"MiCMA: an alternative treatment for refractory or recurrent Hodgkin\u2019s disease","volume":"11","author":"La Barbera","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2020.106427_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096927","article-title":"Peyronie\u2019s disease: lights and shadows","volume":"78","author":"Sasso","year":"2007","journal-title":"Urol. Int."},{"key":"10.1016\/j.leukres.2020.106427_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie\u2019s disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.leukres.2020.106427_bib0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.20972","article-title":"Therapies for bleomycin induced lung fibrosis through regulation of TGF-\u03b21 induced collagen gene expression","volume":"211","author":"Cutroneo","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.leukres.2020.106427_bib0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.cco.0000160750.33552.42","article-title":"Germ cell tumors","volume":"17","author":"Hussain","year":"2005","journal-title":"Curr. Opin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T22:38:59Z","timestamp":1736980739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":12,"alternative-id":["S0145212620301326"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106427","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peyronie\u2019s disease in patients with Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106427"}}